Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan

Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan

Rwanda and Bhutan, 2 low- and middle-income countries, implemented primarily school-based national human papillomavirus (HPV) vaccination in 2011 (Rwanda) and 2010 (Bhutan). We estimated vaccination effectiveness through urine-based HPV prevalence surveys in schools in 2013–2014 and 2017. In Rwanda...

Full description

Bibliographic Details
Main Authors: Iacopo Baussano, Felix Sayinzoga, Ugyen Tshomo, Vanessa Tenet, Alex Vorsters, Daniëlle A.M. Heideman, Tarik Gheit, Massimo Tommasino, Marie Chantal Umulisa, Silvia Franceschi, Gary M. Clifford
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-01-01
Series:Emerging Infectious Diseases
Subjects:
papillomavirus infections
papillomavirus vaccines
human papillomavirus recombinant vaccine quadrivalent
type 6
type 11
type 16
Online Access:https://wwwnc.cdc.gov/eid/article/27/1/19-1364_article

Internet

https://wwwnc.cdc.gov/eid/article/27/1/19-1364_article

Similar Items